Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-10-23
1989-09-12
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
424 851, 424 852, 424 854, 424 855, 424 856, 424 857, 530387, 436527, 435174, 502400, 502407, 604 5, A61K 3900, C12N 1100, G01N 33552
Patent
active
048658413
ABSTRACT:
Antibody is removed from the blood of patients who are being treated or diagnosed with exogenous macromolecules, such as immunotoxins. As the immunotoxins are foreign antigens, the patient will develop an immune response. The antibodies produced by the immune response upon subsequent immunization with the immunotoxins will interfere with the desired function of the immunotoxins by preventing them from binding with their specific target site. By extracorporeally removing the antibodies, the activity of the immunotoxins can be enhanced.
REFERENCES:
patent: 4340535 (1982-07-01), Voisin et al.
patent: 4576928 (1986-03-01), Toni et al.
patent: 4590071 (1986-05-01), Scannon et al.
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4681870 (1987-07-01), Balint, Jr. et al.
Schenkein et al. (1971), J. Clin. Invest. 50:1864.
Terman et al. (1976), Clin. Exp. Immunol. 24:231.
Terman et al. (1976), Clin. Exp. Immunol. 28:130.
Terman et al. (1979), Lancet 2:824.
Balint et al. (1984), Cancer Res. 44:734.
Bensinger et al. (1981), N. Engl. J. Med. 304:160.
Balint, Jr. Joseph P.
Cochran Sharon
Jones Frank R.
Snyder Harry W.
IMRE Corporation
Mohamed Abdel A.
Moskowitz Margaret
LandOfFree
Methods and compositions for transient elimination of humoral im does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for transient elimination of humoral im, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for transient elimination of humoral im will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-914834